Outcome of myeloablative allogeneic stem cell transplantation in multiple myeloma with a 153Sm-EDTMP-based preparative regimen

被引：6
作者：
Kennedy, GA [1 ]
Durrant, S
Butler, J
Morton, J
Western, R
Bartlett, ML
Allison, R
MacFarlane, DJ
机构：
[1] Royal Brisbane & Womens Hosp, Dept Haematol, Div Oncol, Brisbane, Qld 4029, Australia
[2] Royal Brisbane & Womens Hosp, Dept Nucl Med, Brisbane, Qld 4029, Australia
来源：
LEUKEMIA | 2005年 / 19卷 / 05期
关键词：
D O I：
10.1038/sj.leu.2403698
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：879 / 880
页数：2
相关论文
共 5 条
  • [1] Dosimetry and toxicity of Quadramet for bone marrow ablation in multiple myeloma and other haematological malignancies
    Bartlett, ML
    Webb, M
    Durrant, S
    Morton, AJ
    Allison, R
    Macfarlane, DJ
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (11) : 1470 - 1477
  • [2] A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma
    Dispenzieri, A
    Wiseman, GA
    Lacy, MQ
    Litzow, MR
    Anderson, PM
    Gastineau, DA
    Tefferi, A
    Inwards, DJ
    Micallef, INM
    Ansell, SM
    Porrata, L
    Elliott, MA
    Lust, JA
    Greipp, PR
    Rajkumar, SV
    Fonseca, R
    Witzig, TE
    Erlichman, C
    Sloan, JA
    Gertz, MA
    [J]. LEUKEMIA, 2005, 19 (01) : 118 - 125
  • [3] DURRIE B, 1975, CANCER, V36, P842
  • [4] 153Sm EDTMP for bone marrow ablation prior to stem cell transplantation for haematological malignancies
    Macfarlane, DJ
    Durrant, S
    Bartlett, ML
    Allison, R
    Morton, AJ
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2002, 23 (11) : 1099 - 1106
  • [5] Granulocyte-colony-stimulating factor (G-CSF)-primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells
    Morton, J
    Hutchins, C
    Durrant, S
    [J]. BLOOD, 2001, 98 (12) : 3186 - 3191
1